Iron metabolism in end stage renal failure: Rationale for re-evaluation of parenteral iron therapy

Orson W. Moe, Miguel Vazquez, Mariusz Kielar

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose of Review: In this article we will examine the basis for using chronic high dose parenteral iron therapy in dialysis patients. Recent findings: There are increasing data that dialysis patients fare better in many respects if they have higher hematocrit values although the real optimal hematocrit has not been defined. There is an increasing tendency to use parenteral iron to achieve this goal. Summary: Although parenteral iron achieves seemingly favourable short results, there are no data for its safety in the long term. On the contrary, there are reasons to suggest possible iron overload with chronic use.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalCurrent Opinion in Nephrology and Hypertension
Volume12
Issue number2
DOIs
StatePublished - Mar 2003

Fingerprint

Chronic Kidney Failure
Iron
Hematocrit
Dialysis
Iron Overload
Therapeutics
Safety

Keywords

  • Anaemia
  • Iron toxicity
  • Parenteral iron
  • Renal failure

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

@article{3886743fb81b4eefaa6b453ed4a6027c,
title = "Iron metabolism in end stage renal failure: Rationale for re-evaluation of parenteral iron therapy",
abstract = "Purpose of Review: In this article we will examine the basis for using chronic high dose parenteral iron therapy in dialysis patients. Recent findings: There are increasing data that dialysis patients fare better in many respects if they have higher hematocrit values although the real optimal hematocrit has not been defined. There is an increasing tendency to use parenteral iron to achieve this goal. Summary: Although parenteral iron achieves seemingly favourable short results, there are no data for its safety in the long term. On the contrary, there are reasons to suggest possible iron overload with chronic use.",
keywords = "Anaemia, Iron toxicity, Parenteral iron, Renal failure",
author = "Moe, {Orson W.} and Miguel Vazquez and Mariusz Kielar",
year = "2003",
month = "3",
doi = "10.1097/00041552-200303000-00004",
language = "English (US)",
volume = "12",
pages = "145--151",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Iron metabolism in end stage renal failure

T2 - Rationale for re-evaluation of parenteral iron therapy

AU - Moe, Orson W.

AU - Vazquez, Miguel

AU - Kielar, Mariusz

PY - 2003/3

Y1 - 2003/3

N2 - Purpose of Review: In this article we will examine the basis for using chronic high dose parenteral iron therapy in dialysis patients. Recent findings: There are increasing data that dialysis patients fare better in many respects if they have higher hematocrit values although the real optimal hematocrit has not been defined. There is an increasing tendency to use parenteral iron to achieve this goal. Summary: Although parenteral iron achieves seemingly favourable short results, there are no data for its safety in the long term. On the contrary, there are reasons to suggest possible iron overload with chronic use.

AB - Purpose of Review: In this article we will examine the basis for using chronic high dose parenteral iron therapy in dialysis patients. Recent findings: There are increasing data that dialysis patients fare better in many respects if they have higher hematocrit values although the real optimal hematocrit has not been defined. There is an increasing tendency to use parenteral iron to achieve this goal. Summary: Although parenteral iron achieves seemingly favourable short results, there are no data for its safety in the long term. On the contrary, there are reasons to suggest possible iron overload with chronic use.

KW - Anaemia

KW - Iron toxicity

KW - Parenteral iron

KW - Renal failure

UR - http://www.scopus.com/inward/record.url?scp=0037335150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037335150&partnerID=8YFLogxK

U2 - 10.1097/00041552-200303000-00004

DO - 10.1097/00041552-200303000-00004

M3 - Article

C2 - 12589174

AN - SCOPUS:0037335150

VL - 12

SP - 145

EP - 151

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 2

ER -